They act as intermediaries between customers and mail-order compounding pharmacies, which create GLP-1s by mixing active ingredients, such as semaglutide, with additives
Novo Nordisk (Denmark): Novo, as described above, dominates the GLP-1 market with products like Wegovy and Ozempic
By maintaining open communication and tailoring care to each individual, they can ensure patients feel supported, which can boost both adherence to treatment and overall satisfaction
13 Further research is needed to investigate the interconnected pathophysiologic roles of glucagon, GLP-1, and GIP while determining the niche for twincretin therapy in T2DM
Metformin, if not contraindicated, is the preferred first line pharmacological agent for type 2 diabetes 14
To understand what these changes mean for the millions of people who have been using compounded versions of GLP-1s, we asked experts to break down what compounding is, the major differences between brand-name drugs and compounded options, and exactly when we can expect the latter to come off the market
